JCIA
INDV icon

Jackson Creek Investment Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Jackson Creek Investment Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
49,619
-19,931
-29% -$723K 0.66% 5
2026
Q1 		$2.12M Sell
69,550
-2,833
-4% -$93.6K 0.62% 20
2025
Q4 		$2.6M Buy
72,383
+11,493
+19% +$351K 0.77% 5
2025
Q3 		$1.47M Buy
+60,890
New +$1.27M 0.42% 122

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's INDV Position: Q2 2026 in Review

Jackson Creek Investment Advisors reduced its Indivior Pharmaceuticals (INDV) stake by 29% in Q2 2026, selling an estimated $723K and leaving 49,619 shares worth $1.99M. The position accounts for 0.66% of the portfolio, ranked #5.

Jackson Creek Investment Advisors first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.6M in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Jackson Creek Investment Advisors held 49,619 shares of Indivior Pharmaceuticals worth $1.99M as of Q2 2026.
  • Jackson Creek Investment Advisors sold 19,931 Indivior Pharmaceuticals shares in Q2 2026, an estimated $723K.
  • Indivior Pharmaceuticals made up 0.66% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #5 holding.
  • Jackson Creek Investment Advisors first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Jackson Creek Investment Advisors's Indivior Pharmaceuticals position peaked at $2.6M in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.